YARROW BIOSCIENCE, INC. Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount
YARROW BIOSCIENCE, INC. (YARW) reported Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount of $2.00 million for the 12-month period ending 2025-12-31, per its S-4/A filed 2026-06-03.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets
us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount · last filed 2026-06-03
- YARROW BIOSCIENCE, INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2023 was $2.90M, a 123.08% increase from fiscal 2022.
- YARROW BIOSCIENCE, INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2022 was $1.30M, a 91.77% decline from fiscal 2021.
- YARROW BIOSCIENCE, INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2021 was $15.80M.
- YARROW BIOSCIENCE, INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2020 was -$1.30M, a 105.63% decline from fiscal 2019.
| Period end | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month as first filed |
|---|---|---|
| 2025-12-31 | $2.00M S-4/A · filed 2026-06-03 | -$2.00M 10-K · filed 2026-02-27 |
| 2024-12-31 | $10.90M S-4/A · filed 2026-06-03 | |
| 2023-12-31 | $2.90M 10-K · filed 2025-03-06 | |
| 2022-12-31 | $1.30M 10-K · filed 2024-03-01 | |
| 2021-12-31 | $15.80M 10-K · filed 2023-03-14 | |
| 2020-12-31 | -$1.30M 10-K · filed 2022-03-17 | |
| 2019-12-31 | $23.10M 10-K · filed 2021-03-04 | $16.60M 10-K · filed 2020-03-03 |
| 2018-12-31 | $12.60M 10-K · filed 2020-03-03 | |
| 2017-12-31 | $3.40M 10-K · filed 2020-03-03 | |
| 2016-12-31 | $5.00M 10-K · filed 2019-02-28 | |
| 2015-12-31 | $1.90M 10-K · filed 2018-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B |